Role of epidural fat in the local milieu: what we know and what we don't

被引:2
作者
Liu, Zhiming [1 ]
Wang, Yida [1 ]
Ma, Xuexiao [1 ]
Zhang, Lu [2 ]
Wang, Chao [1 ]
机构
[1] Qingdao Univ, Dept Spine Surg, Affiliated Hosp, Qingdao, Peoples R China
[2] Qingdao Univ, Dept Med Res Ctr, Affiliated Hosp, Qingdao, Peoples R China
基金
中国国家自然科学基金;
关键词
Epidural fat; spinal epidural lipomatosis; inflammation; obesity; spinal deformity; hypertrophy; HUMAN-IMMUNODEFICIENCY-VIRUS; FAILED-BACK SYNDROME; LUMBAR DISC SURGERY; STEM-CELLS; ADIPOSE-TISSUE; LIPOMATOSIS; PATIENT; PREVENTION; OBESITY; LAMINECTOMY;
D O I
10.1080/03008207.2024.2329871
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
PurposeTraditionally, the epidural fat (EF) is known as a physical buffer for the dural sac against the force and a lubricant facilitating the relative motion of the latter on the osseous spine. Along with the development of the studies on EF, controversies still exist on vital questions, such as the underlying mechanism of the spinal epidural lipomatosis. Meanwhile, the scattered and fragmented researches hinder the global insight into the seemingly dispensable tissue.MethodsHerein, we reviewed literature on the EF and its derivatives to elucidate the dynamic change and complex function of EF in the local milieu, especially at the pathophysiological conditions. We start with an introduction to EF and the current pathogenic landscape, emphasizing the interlink between the EF and adjacent structures. We generally categorize the major pathological changes of the EF into hypertrophy, atrophy, and inflammation.Results and conclusionsIt is acknowledged that not only the EF (or its cellular components) may be influenced by various endogenic/exogenic and focal/systematic stimuli, but the adjacent structures can also in turn be affected by the EF, which may be a hidden pathogenic clue for specific spinal disease. Meanwhile, the unrevealed sections, which are also the directions the future research, are proposed according to the objective result and rational inference. Further effort should be taken to reveal the underlying mechanism and develop novel therapeutic pathways for the relevant diseases.
引用
收藏
页码:102 / 116
页数:15
相关论文
共 50 条
  • [41] What We Know and What We Need to Know about Aromatic and Cationic Biogenic Amines in the Gastrointestinal Tract
    Fernandez-Reina, Alberto
    Luis Urdiales, Jose
    Sanchez-Jimenez, Francisca
    FOODS, 2018, 7 (09):
  • [42] Analgosedation in neonates: what we know and how we act
    Allegaert, Karel
    Bellieni, Carlo V.
    RESEARCH AND REPORTS IN NEONATOLOGY, 2013, 3 : 51 - 61
  • [43] Napping and Obesity in Adults - What do we Know?
    Wannamethee, Sasiwarang Goya
    CURRENT DIABETES REPORTS, 2024, 24 (11) : 237 - 243
  • [44] Asthma and obesity in children: what do we know?
    Novik, G. A.
    Khaleva, E. G.
    Makarova, S. G.
    Zhdanova, M., V
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (03): : 183 - 191
  • [45] Sexual Orientation and Obesity: What Do We Know?
    VanKim, Nicole A.
    Laska, Melissa N.
    CURRENT OBESITY REPORTS, 2021, 10 (04) : 453 - 457
  • [46] Sexual Orientation and Obesity: What Do We Know?
    Nicole A. VanKim
    Melissa N. Laska
    Current Obesity Reports, 2021, 10 : 453 - 457
  • [47] Metabolic syndrome: is equine disease comparable to what we know in humans?
    Ertelt, Antonia
    Barton, Ann-Kristin
    Schmitz, Robert R.
    Gehlen, Heidrun
    ENDOCRINE CONNECTIONS, 2014, 3 (03): : R81 - R93
  • [48] Schizophrenia and eating disorders: What do we know?
    Mathieu, Sasha
    Varescon, Isabelle
    ANNALES MEDICO-PSYCHOLOGIQUES, 2018, 176 (03): : 231 - 235
  • [49] Lost in translation: the gap between what we know and what we do about cardiovascular
    Chow, Clara K.
    Rodgers, Anthony
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (08) : 291 - +
  • [50] Assessment of Arterial Stiffness Using the Cardio-Ankle Vascular Index - What We Know and What We Strive for
    Sumin, A. N.
    Shcheglova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (04) : 619 - 627